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INTRODUCTION
Bacillus anthracis is a Gram-positive pathogen that is the etiological agent of the disease anthrax. The virulence of B. anthracis is attributed to three major factors: a γ -linked poly-D-glutamic acid capsule and two binary toxins, lethal toxin (LT) and edema toxin (ET). The capsule, encoded on plasmid pXO2, is believed to enhance virulence by its antiphagocytic properties (Scorpio et al. 2008) . The A-B toxins, encoded on plasmid pXO1, share a binding partner, protective antigen, which pairs with lethal factor to form LT or with edema factor to form ET. LT cleaves mitogenactivated protein-kinase kinases and ET functions as an adenylate cyclase to increase intracellular cAMP levels (Tournier et al. 2009 ). These activities result in the dysregulation of key signaling networks in myeloid cells leading to impairment of the host innate and adaptive immune systems, and in late stages, damage the cardiovascular system and liver (Tournier et al. 2009 ).
Human infection occurs because of exposure to B. anthracis spores. Infection is acquired through gastrointestinal, cutaneous or inhalational routes. Most natural infections occur through the cutaneous route with minimal mortality, whereas inhalational anthrax is much more likely to result in death (Inglesby et al. 2002) . The prolonged environmental persistence of the spores combined with the potential for their large-scale dissemination, realized in the 2001 mailing of the Anthrax Letters, has garnered the interest of the biomedical community and the public to improve current prevention and therapeutic strategies against B. anthracis (Inglesby et al. 2002) .
After water, tea is the most consumed beverage in the world. Although containing little caloric value, teas have potent antimutagenic, antidiabetic, anti-angiogenic and antiinflammatory activity (Cabrera, Artacho and Gimenez 2006; Moore, Jackson and Minihane 2009) . Green and black teas are dried leaves of Camellia sinensis. After harvest, green tea undergoes a heating process that inactivates the enzyme polyphenol oxidase. In contrast, black tea is not heated, thus allowing the enzyme to function during tea processing. Thus, both green and black teas contain similar amounts, but different compositions of simple polyphenols (Cabrera, Artacho and Gimenez 2006) . Whereas the polyphenol catechins predominate and represent 10%-15% of the dry weight in green tea, these simple polyphenols have been converted to their oxidized counterparts in black tea (Zhao et al. 2001) . Importantly, of the four major catechins in green tea, EGCG predominates, representing more than 50% of the total catechins (Nagle, Ferreira and Zhou 2006) .
Green tea has potent antimicrobial activity, which is attributed to EGCG because of its relatively high abundance (Toda et al. 1989; Hamilton-Miller 1995; Sharma et al. 2012) . EGCG demonstrates a broad range of antimicrobial activity, with inhibitory effects on viral, bacterial and fungal pathogens (Steinmann et al. 2013) . EGCG is especially effective against Gram-positive bacteria (Zhao et al. 2001; Yoda et al. 2004) . The main mechanism of EGCG's antimicrobial action has been postulated to be lipid bilayer damage (Ikigai et al. 1993) , and more recent evidence suggests that EGCG also binds bacterial peptidoglycan resulting in compromise of the Gram-positive cell wall (Zhao et al. 2001) . In addition, EGCG has been shown to reduce survival of Listeria monocytogenes, Mycobacterium tuberculosis and Legionella pneumophila in macrophages by modulating cellular functions (Matsunaga et al. 2001; Anand, Kaul and Sharma 2006; Kohda, Yanagawa and Shimamura 2008) . In the context of B. anthracis, EGCG inhibits LT function and protects macrophages and rats from LT-induced death (Dell'Aica et al. 2004) . However, to date, no data exist regarding the effect of green tea or EGCG on the growth and viability of B. anthracis.
First, the effect of green tea was evaluated against an unencapsulated strain of B. anthracis (ANR) under in vitro growth conditions. Next, we assessed the inhibitory activity of EGCG against B. anthracis ANR in human blood. Last, the promising inhibitory and killing activity against the unencapsulated ANR strain prompted us to test the activity of EGCG against the virulent, encapsulated B. anthracis Ames strain.
MATERIALS AND METHODS

Bacterial strains and culture
Vegetative unencapsulated Bacillus anthracis ANR (pXO1+, pXO2-) and encapsulated B. anthracis Ames (pXO1+, pXO2+) (US Army Medical Research Institute of Infectious Diseases) were grown overnight from spores in liquid cultures and used to inoculate growth medium. All cultures were shaken at 37
• C with 5% CO 2 . All work with B. anthracis Ames was performed under Biosafety Level 3 containment conditions. MO) . Broth was combined with tea, while maintaining a constant concentration of LB, BHI and/or FBS, and inoculated 1:100 with an overnight culture of bacilli. Whole blood samples were collected from healthy unvaccinated volunteers in vacutainers containing sodium polyanetholesulfate (BD, Franklin Lakes, NJ, USA). Research involving human subjects was conducted in compliance with Department of Defense, Federal, and State statutes and regulations relating to the protection of human subjects and adheres to the principles identified in the Belmont Report (1979) . All data and human subject research were gathered and conducted under human use protocol # FY10-09. Five milliliters of normal saline (0.9% NaCl) (control) or saline containing EGCG (experimental) was added to 15 mL of whole blood for each condition.
Growth medium preparation and blood collection
Tea and EGCG preparation
Three tea bags (STASH C premium green or English black breakfast tea, Portland, OR, USA) were steeped in 120 mL boiling water for 3 min and sterilized through a 0.2-μm filter. Epigallocatechin-3-gallate (EGCG) (Sigma, St. Louis, MO) was solubilized in normal saline. Solutions of EGCG were prepared immediately prior to experiments and sterilized through a 0.2-μm filter.
Optical density measurements and colony forming units counts
Optical density (OD) readings were taken at 600 nm using a Beckman DU530 Life Science UV/vis Spectrophotometer. Cultures were serially diluted and plated either on Tryptic Soy or Sheep Blood Agar plates (Remel, Lenexa, KS) and incubated overnight at 37
• C.
Live/dead assay and confocal microscopy LIVE/DEAD Baclight Bacterial Viability Kit (Life Technologies, Grand Island, NY) was used in accordance with the manufacturer's protocol. Images were taken on the Zeiss 700 Laser Scanning Confocal Microscope System using either a 40x/1.3 or a 100x/1.4 numerical aperture oil objectives lens with the pinhole set to 1 Airy unit. All images shown are maximum intensity projections and bars on images denote 20 μm in length.
Statistical analyses
Microsoft Excel was used to analyze data and generate graphs. Statistical significance was determined using an unpaired Student's t test at graphpad.com. Error bars denote standard error of the mean (SEM). 
RESULTS
Bacillus anthracis ANR is killed in the presence of green tea
In LB with 10% green tea, B. anthracis ANR growth was significantly inhibited after 4 h, with a 2 log difference between 10% green tea and the culture grown without tea (Fig. 1A) . Black tea also inhibited in vitro growth (P = 0.08) but to a lesser extent than green tea (Fig. 1A) . Because green tea strongly inhibited growth, the effects of time and increasing green tea concentration ranging from 10% to 50% were examined. Bacterial cultures subjected to green tea did not increase in turbidity, whereas bacilli grown without tea did (Fig. 1B) . Hence, green tea inhibits the growth of B. anthracis ANR.
Bacillus anthracis forms chains of bacilli (Chabot et al. 2012) . To assess if green tea resulted in killing of individual bacillus within a chain, we performed a Live/Dead bacterial viability assay with confocal microscopy imaging. Bacilli in chains were manually scored live or dead based on the exclusion or inclusion of propidium iodide, respectively. Empty spaces within the chains, which are cell wall remnants of dead bacilli, were also scored as killed. In the presence of green tea, a decrease in the percentage of live bacilli was observed compared to the culture without tea (Fig. 1C  and D) . Interestingly, the effect of green tea on individual bacilli appeared to be random as live and dead bacilli can both be seen on a single chain (Fig. 1D) . Also, killing was concentration dependent as increasing concentration of tea resulted in less live bacilli ( Fig. 1C and D) . Thus, green tea inhibits the growth of B. anthracis ANR by a bactericidal mechanism.
The presence of serum decreases the bactericidal activity of green tea
We next examined the activity of green tea in LB or BHI media that contained NaHCO 3 and FBS (LB/FBS or BHI/FBS). Interestingly, we found that a higher percentage of live bacilli were present in LB/FBS + 50% tea versus LB + 50% tea without FBS ( Fig. 2A) . Similarly, a higher percentage of live bacilli were scored in BHI/FBS with tea compared to BHI with tea ( Fig. 2A) . This showed that although green tea continues to inhibit bacilli growth in the presence of serum, FBS contains compounds that interfere with green tea's bactericidal activity.
Albumin is partially responsible for interfering with the bactericidal activity of green tea
Albumin is the most abundant protein found in serum and binds a variety of endogenous and exogenous substances (Zsila, Bikadi and Simonyi 2003; Fasano et al. 2005; Bae et al. 2009 ). To determine if albumin was responsible for interfering with green tea's bactericidal effect, BSA was substituted in place of FBS (BHI/BSA). Compared to BHI alone, there were more live bacilli counted after growth in BHI/BSA ( Fig. 2B and C) . However, there were less live bacilli in BHI/BSA than in BHI/FBS ( Fig. 2B and C) . Thus, BSA interferes with green tea's bactericidal effect. However, because BSA did not fully recapitulate the mitigating effects of FBS, it also suggests that there may be other components in serum that can interfere with the antimicrobial activity of green tea. Another possibility is that the addition of BSA or FBS provides B. anthracis with a richer medium for growth, thus increasing B. anthracis viability, even in the presence of green tea.
Bacillus anthracis ANR killing in BHI/FBS and blood by EGCG
Because green tea's antimicrobial activity is mainly attributed to the most abundant catechin EGCG, we next explored the effect of EGCG against unencapsulated B. anthracis ANR. The average EGCG content of brewed green tea is ∼1.6 mM, but the range of 50 μM to 4.5 mM has been reported (Higdon and Frei 2003; Zaveri 2006; Bhagwat, Haytowitz and Holden 2014) . The maximum plasma concentration of EGCG that has been observed following oral ingestion in humans is ∼7 μM, but varies greatly (0.1 to 7 μM) and is directly proportional to the amount of tea or extract ingested (Lee et al. 2002; Chow et al. 2003; Ullmann et al. 2003 ). Therefore, we tested the effects of EGCG, ranging from 7 μM to 1.6 mM, on the growth of B. anthracis ANR in BHI broth with and without FBS. Without FBS, there was significant inhibitory activity at concentrations of 70 μM and greater (Fig. 3A) . Without FBS, 7 μM EGCG also inhibited growth, albeit without statistical significance (P = 0.09) (Fig. 3A) . In the presence of FBS, there was significant inhibitory activity with 1.6 mM EGCG (Fig. 3B) . EGCG (700 μM) showed some growth inhibition but this did not reach statistical significance (P = 0.09) (Fig. 3B) . When assessed by the Live/Dead assay, treatment with 1.6 mM EGCG showed significant killing of bacilli at both 4 and 7 h in the absence of FBS. With FBS, the killing activity of EGCG was mitigated at both time points (Fig. 3C) . EGCG reaches systemic circulation after green tea consumption (Ullmann et al. 2003) . Therefore, the effect of EGCG on B. anthracis ANR growth was also examined in human blood. In the presence of 1.6 mM EGCG, a growth inhibition trend was observed in the blood at 6 and 24 h, but this did not reach statistical significance (Fig. 3D) . The difference in EGCG potency in = 2528, n = 3, * P < 0.05, * * P < 0.01. (D) CFU mL −1 of bacilli grown in human blood with 1.6 mM EGCG for 6 or 24 h. n = 3 media with bovine (BHI/FBS) or human serum (blood) might be explained by the differences in serum amounts or composition. Taken together, these data suggest that components in serum interfere with the bactericidal activity of EGCG, but can be overcome with higher concentrations of EGCG that saturate the inhibitory components in serum.
Green tea and EGCG inhibit the growth of Bacillus anthracis Ames
The B. anthracis capsule is a virulence factor that acts as a protective coat surrounding the bacilli preventing phagocytosis and precluding molecules from reaching the bacterial cell wall (Scorpio et al. 2008) . Thus, the activity of EGCG against the encapsulated B. anthracis Ames was examined. First, the growth of virulent bacilli was examined in BHI ± FBS with 70 μM or 1.6 mM EGCG. Notably, even in the presence of FBS, which was shown earlier to interfere with killing activity of green tea, 1.6 mM EGCG resulted in a 3 log decrease in colony forming unit (CFU) mL
over the course of 6 h ( Fig. 4A and B) . For cultures treated with 70 μM EGCG, although no CFU count differences were seen, smaller colonies resulted when grown compared to timematched cultures that received no EGCG (Fig. 4C ). These data suggest that strain differences (ANR versus Ames) contribute to differential susceptibilities to EGCG. EGCG was also evaluated against the growth of B. anthracis Ames in human blood. At 24 h, there was a significant one log reduction in CFU mL −1 in the presence of EGCG compared to cultures without. As noted before, the lower potency of 1.6 mM EGCG in blood (as compared to growth media) might be attributed to differences in the amount of inhibitory components in human versus bovine sera.
DISCUSSION
Previous work has showed that black tea is bactericidal towards the unencapsulated, avirulent Sterne strain of Bacillus anthracis (Baillie and Gallagher 2008) . Our work demonstrates the ability of green tea and its constituent catechin EGCG to inhibit the growth of and kill the unencapsulated B. anthracis ANR strain. Notably, our investigation also shows that green tea and EGCG exhibit bactericidal activity against an encapsulated strain, B. anthracis Ames.
Mechanistic studies of EGCG's bactericidal activity against the Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) have revealed that EGCG binds to peptidoglycan, resulting in impaired cell division and cell lysis (Zhao et al. 2001) . Thus, EGCG likely binds to the cell wall of B. anthracis to cause lysis. Moreover, EGCG's activity against encapsulated B. anthracis suggests that the capsule is permeable to EGCG. Alternatively, there may be areas on the bacilli devoid of capsule, allowing the compound to reach the peptidoglycan beneath it. Thus, in addition to inhibiting the B. anthracis LT (Dell'Aica et al. 2004) , EGCG is also bactericidal toward B. anthracis. The highest concentration of EGCG measured in human plasma is 7 μM after ingestion of a single 1600 mg dose. The large difference in amount of EGCG consumed and the concentration found in systemic circulation is due to the breakdown of EGCG by intestinal microorganisms, poor absorption by the small intestine and active removal by efflux transporters (Hara 1997; Feng 2006; Lambert et al. 2006 ). Although we did not see effective killing at 7 μM, it may be possible to achieve higher concentrations in blood if EGCG is administered intravenously. EGCG has been shown to have minimal toxicity in animals and humans (Yamada et al. 1998) . Indeed, injection of EGCG to achieve an estimated circulating dose of 100 μM in Fischer 344 rats allowed some to recover from LT-induced toxicity. Moreover, rats and mice that were injected with EGCG alone did not experience adverse reactions (Dell'Aica et al. 2004 ). Thus, intravenous administration of higher and repeated dosing of EGCG should be evaluated for safety and efficacy in animal models of anthrax.
To increase the bioavailability of EGCG in the systemic circulation, alternative delivery systems or chemical modification of EGCG should also be considered. A recent report has shown that the nanoencapsulation of EGCG allows sustained release and site-specific targeting of the molecule (Fangueiro et al. 2016) . In addition, peracetylated EGCG has increased biological potency and bioavailability, though once converted back to the parent compound, it undergoes the same degradation and metabolism described previously (Lambert et al. 2006) . Alternatively, a different route of administration that prevents EGCG from being rapidly metabolized or inactivated, such as a nebulized form of EGCG, should be considered. Others have shown that the nebulized form of tea catechins is safe and effective against MRSA in the respiratory tract of humans (Yamada et al. 2003) . Therefore, future studies should address alternative routes of delivery for EGCG in order to avoid metabolic processes, chemical degradation and inactivation by serum albumin and other blood constituents.
Furthermore, it is important to explore the pharmacodynamic relationship of EGCG with existing antibiotics. Importantly, synergy with another antimicrobial would reduce the required amount of EGCG to achieve a bactericidal concentration in vivo. Zhao et al. (2001) have shown synergy between EGCG and β-lactams. Although some strains of B. anthracis have been reported as resistant, most strains are susceptible to β-lactams (Luna et al. 2007 ). Thus, EGCG might synergize with β-lactams to enhance killing of B. anthracis.
